Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does IFOSFAMIDE Cause Neoplasm recurrence? 85 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 85 reports of Neoplasm recurrence have been filed in association with IFOSFAMIDE (IFEX). This represents 0.5% of all adverse event reports for IFOSFAMIDE.

85
Reports of Neoplasm recurrence with IFOSFAMIDE
0.5%
of all IFOSFAMIDE reports
13
Deaths
16
Hospitalizations

How Dangerous Is Neoplasm recurrence From IFOSFAMIDE?

Of the 85 reports, 13 (15.3%) resulted in death, 16 (18.8%) required hospitalization, and 24 (28.2%) were considered life-threatening.

Is Neoplasm recurrence Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for IFOSFAMIDE. However, 85 reports have been filed with the FAERS database.

What Other Side Effects Does IFOSFAMIDE Cause?

Off label use (2,281) Febrile neutropenia (2,225) Disease progression (1,912) Neutropenia (1,509) Drug ineffective (1,331) Thrombocytopenia (1,227) Anaemia (1,067) Product use in unapproved indication (890) Pyrexia (752) Sepsis (712)

What Other Drugs Cause Neoplasm recurrence?

CYCLOPHOSPHAMIDE (293) PALBOCICLIB (248) DOXORUBICIN (240) VINCRISTINE (239) CYTARABINE (223) METHOTREXATE (198) CARBOPLATIN (170) RITUXIMAB (163) ETOPOSIDE (156) PREDNISONE (144)

Which IFOSFAMIDE Alternatives Have Lower Neoplasm recurrence Risk?

IFOSFAMIDE vs IGURATIMOD IFOSFAMIDE vs ILOPERIDONE IFOSFAMIDE vs ILOPROST IFOSFAMIDE vs IMATINIB IFOSFAMIDE vs IMBRUVICA

Related Pages

IFOSFAMIDE Full Profile All Neoplasm recurrence Reports All Drugs Causing Neoplasm recurrence IFOSFAMIDE Demographics